We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results (5)

« Back to Publications

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Paganotti Vicentine M. et al, (2026), BMJ Open, 16

Towards paratyphoid control: the vital role of the challenge model.

McCann N. et al, (2024), Lancet, 403, 2780 - 2781

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines.

McCann N. et al, (2024), Front Immunol, 15

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.

McCann N. et al, (2023), BMJ Open, 13

Viral vector vaccines.

McCann N. et al, (2022), Curr Opin Immunol, 77